BioSpace News Archive

Pharm Country

New Cancer Treatment Developed by LIMR Scientists Inhibits Tumor Growth and Boosts Anti-Tumor Immune Response

Cancer researchers at the Lankenau Institute for Medical Research have developed a novel treatment that inhibits the growth of malignant tumors and activates an immune response to those tumors.

November 13, 2017

·

3 min read

Business

SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Total operating expenses for the third quarter of 2017 were $5.4 million, compared to $8.0 million for the third quarter of 2016.

November 13, 2017

·

8 min read

Drug Development

International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson’s Disease Clinical Trial

All patients in the first cohort are currently meeting the primary endpoint, which is safety.

November 13, 2017

·

7 min read

Drug Development

Galectin: Combination Immunotherapy of Pembrolizumab With the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma From a Phase Ib Clinical Trial

The objective response rate in advanced melanoma was 62.5% (five of eight subjects).

November 13, 2017

·

7 min read

ARCEDI Biotech Announces Launch of First and Only Non-Invasive Prenatal Testing Based on Fetal Cells in Maternal Blood In Denmark

ARCEDI Biotech ApS today announced that the Company’s non-invasive prenatal testing technology based on fetal cells enriched from maternal blood will be implemented at hospitals within the Central Denmark region and further holds potential for worldwide implementation.

November 13, 2017

·

4 min read

Drug Development

80% of Prostate Cancer Patients in OncBioMune Phase I Clinical Trial of ProscaVax Show No Disease Progression at the First Post-Therapy Follow-up

The latest data updates the progression results at 19 weeks for all 20 patients.

November 13, 2017

·

2 min read

Aslan Pharma Announces Poster Presentation at Esmo Asia Congress 2017

ASLAN Pharma today announced that it will be presenting data from its phase II trial of varlitinib in metastatic HER2-positive breast cancer patients at the ESMO Asia Congress 2017.

November 13, 2017

·

1 min read

Drug Development

C4X Discovery C4XD Presents Data on its Lead Addiction Programme: Orexin-1 Antagonist

C4X Discovery presented new pre-clinical data on its Orexin-1 antagonist programme at Neuroscience 2017 on 11th November 2017 in Washington, DC.

November 13, 2017

·

1 min read

Biotech Beach

Peregrine Announces Date of 2017 Annual Meeting of Stockholders

Holders of the company’s common stock at the close of business on November 27, 2017 will be entitled to receive notice of and vote their shares at the 2017 Annual Meeting.

November 13, 2017

·

3 min read

Business

Rexgenero Announces the Appointment of Sam MacHour to its Scientific Advisory Board

Rexgenero is pleased to announce today the appointment of Sam MacHour to its SAB.

November 13, 2017

·

2 min read